Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: J.F. who wrote (20953)	12/12/2006 7:55:01 PM
From: ACAN	Respond to of 23958

jf; I think any body under three, or over 3 will be fascinated by it . When they ran out of supply in October, there were 2 offered on EBay for $3200, if you can believe. ----------------------------------------------------------------[NXXI] N21's Chromium P-Metformin Pilot Trial (6 Ratings) 3-Dec-06 03:51 pm Study ends Dec.31 2006. N21 is the supplier of Chromium Picolinate for this study. An unprecedented combination with Merck´s blockbuster Metformin drug for Diabetes Type 2. When results get published next year, we´ll have a TEN SHORT TERM BAGGER in our hands. Trust me!!! Sentiment : Strong Buy -------------------------------------------------------------- Perhaps too enthusiastic a prediction, but could be some leaks to account for volume at due spot